Glenmark Slapped With Sanctions In Tarka ANDA Suit

Law360, New York (July 1, 2010, 6:42 PM EDT) -- A federal judge has partially granted Sanofi-Aventis Deutschland GmbH and Abbott Laboratories’ request for sanctions against Glenmark Ltd. in a patent feud over Glenmark's proposed generic formulation of Abbott’s high blood pressure drug Tarka.

Judge Dennis M. Cavanaugh of the U.S. District Court for the District of New Jersey said in a ruling Thursday that Glenmark had destroyed evidence relevant to the reasonably foreseeable litigation associated with filing an abbreviated new drug application. The amount of the sanctions was not disclosed in the order.

The plaintiffs...
To view the full article, register now.